Skip to main content

Peer Review reports

From: Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA

Original Submission
7 Apr 2016 Submitted Original manuscript
26 May 2016 Reviewed Reviewer Report - Barbara Jarzab
29 May 2016 Reviewed Reviewer Report - Alessandro Antonelli
6 Jun 2016 Author responded Author comments - Monika Wagner
Resubmission - Version 2
6 Jun 2016 Submitted Manuscript version 2
19 Dec 2016 Reviewed Reviewer Report - Alessandro Antonelli
2 Jan 2017 Reviewed Reviewer Report - Dawen Sui
12 Jan 2017 Author responded Author comments - Monika Wagner
Resubmission - Version 3
12 Jan 2017 Submitted Manuscript version 3
29 Mar 2017 Author responded Author comments - Monika Wagner
Resubmission - Version 4
29 Mar 2017 Submitted Manuscript version 4
Publishing
3 Apr 2017 Editorially accepted
17 Apr 2017 Article published 10.1186/s12885-017-3258-9

You can find further information about peer review here.

Back to article page